CD85d (ILT4) Antibody, anti-human, PE, REAfinity™ 130-100-564 from Miltenyi Biotec

Product Specs
ItemCD85d (ILT4) Antibody, anti-human, PE, REAfinity™
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-100-564
Regulatory StatusFor research use only
Concentration1:11
ModificationsRecombinantly engineered
Domain/Region/TerminusFc region
Research AreaFor research use only
ApplicationsFlow Cytometry (FCM)
ReactivityHuman (Hu)
Clonalitymonoclonal
NCBI Gene AliasesCD85D, ILT-4, ILT4, LIR-2, LIR2, MIR-10, MIR10
NCBI Full Gene Nameleukocyte immunoglobulin like receptor B2
Antibody TypePrimary antibodies, Recombinant antibodies
Hosthuman cell line
CloneREA184
IsotypeIgG1
TargetCD85d (ILT4)
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
Conjugate/TagPE
Quantity100 tests in 1 mL

Add to Compare List

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1) Integrating Proteomics and Transcriptomics for Systematic Combinatorial Chimeric Antigen Receptor Therapy of AMLCancer cellOctober 9, 2017Perna F, Berman SH, Soni RK, Mansilla-Soto J, Eyquem J, Hamieh M, Hendrickson RC, Brennan CW, Sadelain M.technologies, A15799); CD70-PE, -FITC (Biolegend, 355104, 355106); CD85d (ILT4)-PE -APC (Miltenyi, 130–100-567, 130–100-559); LTB4R1-AF700 (Novus Biologicals, FAB099N); CD85h (ILT1)-APC (Miltenyi, 130–100-920);

(2) Angiopoietin-like protein 2 regulates Porphyromonas gingivalis lipopolysaccharide-induced inflammatory response in human gingival epithelial cellsPloS oneJanuary 1, 2017Ohno T, Yamamoto G, Hayashi JI, Nishida E, Goto H, Sasaki Y, Kikuchi T, Fukuda M, Hasegawa Y, Mogi M, et al.anti-CD49e phycoerythrin (Miltenyi Biotec, Cat:130092-215), anti-CD85d phycoerythrin (Miltenyi Biotec, Cat:130-100-567) or isotype control antibody (Miltenyi Biotec, Cat:130-097-225) and analysed by flow cytometry using

(3) Mechanisms of prolongation of allograft survival by HLA-G/ILT4-modified dendritic cellsHuman immunologyApril 1, 2007Ristich V, Zhang W, Liang S, Horuzsko A.

(4) Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d)Proceedings of the National Academy of Sciences of the United States of AmericaOctober 31, 2006Shiroishi M, Kuroki K, Rasubala L, Tsumoto K, Kumagai I, Kurimoto E, Kato K, Kohda D, Maenaka K.

(5) Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-GProceedings of the National Academy of Sciences of the United States of AmericaJuly 22, 2003Shiroishi M, Tsumoto K, Amano K, Shirakihara Y, Colonna M, Braud VM, Allan DS, Makadzange A, Rowland-Jones S, Willcox B, et al.

Be the First to Write a Review!

CD85d (ILT4) Antibody, anti-human, PE, REAfinity™ from Miltenyi Biotec

Miltenyi Biotec

Miltenyi Biotec

Citations (5)

Reviews

CD85d (ILT4) Antibody, anti-human, PE, REAfinity™ from Miltenyi Biotec

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map